Overview

The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia

Status:
Terminated
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This comparison is made between the effects of sertindole and risperidone on vulnerability indicators in schizophrenia. More specifically: the effects of these two antipsychotic compounds on basic processing of incoming information is studied. The investigators expect that the newer antipsychotic sertindole to be more effective in restoring information processing in schizophrenia patients than risperidone.
Phase:
Phase 4
Details
Lead Sponsor:
Birte Glenthoj
Collaborator:
Icahn School of Medicine at Mount Sinai
Treatments:
Risperidone
Sertindole